Xofigo (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Xofigo drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Radioactive alpha-Particle Emitting Therapeutic Agent [EPC],alpha-Particle Emitting Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Radium Ra 223 dichloride |
| SUBSTANCE NAME: | RADIUM RA-223 DICHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radioactive alpha-Particle Emitting Therapeutic Agent [EPC],alpha-Particle Emitting Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-05-20 |
| END MARKETING DATE: | 0000-00-00 |
Xofigo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Xofigo from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30(uCi/mL) |
| START MARKETING DATE: | 2013-05-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-208_f45869fa-8747-4375-86cd-bfd46620d088 |
| PRODUCT NDC: | 50419-208 |
| APPLICATION NUMBER: | NDA203971 |
Other RADIUM RA-223 DICHLORIDE Pharmaceutical Manufacturers / Labelers:
